First Trust Advisors LP Pfizer Inc Transaction History

First Trust Advisors LP

$95.8 Billion
Q1 2024

A detailed history of First Trust Advisors LP transactions in Pfizer Inc stock. As of the latest transaction made, First Trust Advisors LP holds 14,348,173 shares of PFE stock, worth $401 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

14,348,173

Previous 20,396,745 29.65%

Holding current value

$401 Million

Previous $587 Million 32.2%

% of portfolio

0.42%

Previous 0.65%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $157 Million - $180 Million	-6,048,572 Reduced 29.65%	14,348,173 $398 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $31.3 Million - $40.7 Million	-1,197,755 Reduced 5.55%	20,396,745 $587 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $67.5 Million - $78.9 Million	2,103,593 Added 10.79%	21,594,500 $716 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $324 Million - $374 Million	8,960,028 Added 85.08%	19,490,907 $715 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $53.7 Million - $69.9 Million	1,363,186 Added 14.87%	10,530,879 $430 Million

Q4 2022 Feb 09, 2023	BUY	$41.75 - $54.5 $143 Million - $187 Million	3,424,236 Added 59.62%	9,167,693 $470 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $316,384 - $386,226	-7,230 Reduced 0.13%	5,743,457 $251 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $100 Million - $119 Million	-2,158,978 Reduced 27.3%	5,750,687 $302 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $188 Million - $233 Million	4,112,528 Added 108.31%	7,909,665 $409 Million
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $24.7 Million - $36.6 Million	-598,029 Reduced 13.61%	3,797,137 $224 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $19 Million - $24.4 Million	-484,015 Reduced 9.92%	4,395,166 $189 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $35.4 Million - $40.1 Million	-985,506 Reduced 16.8%	4,879,181 $191 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $100 Million - $113 Million	-2,987,901 Reduced 33.75%	5,864,687 $213 Million
Q4 2020 Feb 02, 2021	BUY	$33.47 - $42.56 $9.17 Million - $11.7 Million	273,868 Added 3.19%	8,852,588 $326 Million
Q3 2020 Nov 05, 2020	BUY	$31.75 - $37.25 $30.9 Million - $36.2 Million	972,021 Added 12.78%	8,578,720 $315 Million
Q2 2020 Jul 22, 2020	BUY	$30.12 - $36.54 $89.5 Million - $109 Million	2,973,005 Added 64.16%	7,606,699 $249 Million
Q1 2020 May 06, 2020	BUY	$27.03 - $38.62 $14.5 Million - $20.8 Million	537,782 Added 13.13%	4,633,694 $151 Million
Q4 2019 Feb 03, 2020	BUY	$32.92 - $37.36 $33.1 Million - $37.5 Million	1,004,282 Added 32.48%	4,095,912 $160 Million
Q3 2019 Nov 04, 2019	BUY	$32.49 - $42.13 $17.3 Million - $22.4 Million	531,064 Added 20.74%	3,091,630 $111 Million
Q2 2019 Jul 30, 2019	SELL	$36.98 - $41.52 $78.9 Million - $88.6 Million	-2,134,011 Reduced 45.46%	2,560,566 $111 Million
Q1 2019 May 09, 2019	BUY	$37.5 - $41.2 $10.4 Million - $11.4 Million	276,557 Added 6.26%	4,694,577 $199 Million
Q4 2018 Feb 07, 2019	BUY	$38.47 - $43.86 $25.4 Million - $28.9 Million	659,735 Added 17.55%	4,418,020 $193 Million
Q3 2018 Oct 25, 2018	SELL	$34.47 - $41.81 $12.3 Million - $14.9 Million	-355,812 Reduced 8.65%	3,758,285 $166 Million
Q2 2018 Aug 02, 2018	SELL	$32.98 - $35.16 $8.95 Million - $9.54 Million	-271,311 Reduced 6.19%	4,114,097 $149 Million
Q1 2018 Apr 23, 2018	BUY	$31.91 - $37.02 $22.2 Million - $25.7 Million	695,205 Added 18.84%	4,385,408 $156 Million
Q4 2017 Feb 08, 2018	BUY	$33.26 - $35.29 $5.81 Million - $6.17 Million	174,728 Added 4.97%	3,690,203 $134 Million
Q3 2017 Oct 24, 2017	BUY	$31.0 - $34.15 $109 Million - $120 Million	3,515,475	3,515,475 $126 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Pfizer Inc Transaction History